Research and Development

New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …

Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …

AstraZeneca has signed a deal with UK biotech firm Silence Therapeutics to develop a range of novel approaches for the …

A new Biomedical Research Centre of excellence is to be created in Manchester to help the UK bridge the gap …

GlaxoSmithKline has informed regulators in the US and Europe that a small number of patients taking its new breast cancer …

Regulatory problems and doubts about commercial potential have led Lilly to abandon its late-stage inhaled insulin product. The AIR insulin …

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …

GlaxoSmithKline says its new breast cancer drug Tyverb is ready for launch and could be prescribed to the first UK …

Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …

Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …

Research charity the Wellcome Trust will increase its funding for medical research by more than £1 billion over the next …

Swedish biopharmaceutical company Biovitrum is to turn its back on mass market disease areas and re-focus around specialist care projects. …

Pharma companies should engage diagnostics companies in early phase talks if they want to fast-track innovative new cancer treatments to …